- Report
- November 2024
- 194 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
- Report
- January 2025
- 80 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Book
- July 2023
- 1568 Pages
Butorphanol is an analgesic drug used to treat moderate to severe pain. It is a synthetic opioid agonist-antagonist, meaning it has both agonist and antagonist properties. It is a Schedule IV controlled substance in the United States, meaning it has a low potential for abuse and dependence. Butorphanol is available in both intranasal and injectable forms, and is commonly used in the treatment of migraine headaches, postoperative pain, and labor pain. It is also used to treat opioid withdrawal symptoms.
Butorphanol is generally considered to be a safe and effective analgesic, with few side effects. Common side effects include nausea, dizziness, and drowsiness. It is important to note that butorphanol should not be used in combination with other opioids, as this can increase the risk of serious side effects.
Some companies in the butorphanol market include Endo Pharmaceuticals, Mylan Pharmaceuticals, and Teva Pharmaceuticals. Show Less Read more